Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

GFAP levels increased in the placebo group, but stayed stable with Ambroxol, suggesting that the cough medicine may have the potential to protect the brain from faster deterioration under ...

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph’s Health Care London, are investigating whether Ambroxol - a cough medicine used safely for decades in Europe ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating whether Ambroxol—a cough medicine used safely for decades in Europe ...